Artizan Biosciences Announces Multi-Year Research Collaboration with the University Medical Center Utrecht and Microviable Therapeutics SL
We look forward to working with UMC Utrecht and Microviable to identify potential solutions that can improve patient outcomes and reduce the side effects of ICI treatment.
- We look forward to working with UMC Utrecht and Microviable to identify potential solutions that can improve patient outcomes and reduce the side effects of ICI treatment.
- Artizan is creating multiple programs validated by strategic alliances that include Biohaven Pharmaceuticals, Brii Biosciences, and Crohns and Colitis Foundation.
- The University Medical Center of Utrecht (UMC Utrecht) is one of the largest public healthcare institutions in the Netherlands.
- UMC Utrecht is one of the participating centers in the NFU, which is the Dutch organization for University Medical Centers.